HomeMedical SpecialtiesMEDICAL SPECIALTIESDisease causing mutation found in French-Canadians

Disease causing mutation found in French-Canadians

Published on

Carriers at higher risk of developing neurodegenerative disease

A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).

The mutation, known as p.Trp378Gly, is in the GBA gene, one of the most prominent genes involved in PD. The most common GBA mutations create a small risk of developing synucleinopathies, but in combination with other mutations the risk can increase dramatically.

The study found that one per cent of French Canadians with synucleinopathies have the GBA mutation. This mutation is specific to French Canadians and was probably inherited from a single common ancestor.

People who inherit this gene mutation from one parent become carriers of the mutation and are at risk of developing synucleinopathies. Those who inherit this gene mutation in addition to another mutation in GBA from both parents will develop Gaucher’s disease (GD). GD symptoms include enlargement of the spleen and liver, low red blood cell level, lung disease, arthritis, bone pain and fractures, but symptoms vary among patients.

“We don’t know how frequent this mutation is in the general French-Canadian population, but it doesn’t appear to be very common. We’re going to test additional subjects so we can determine its exact frequency,” says Dr. Ziv Gan-Or, a genetics researcher at The Neuro and the study’s lead author. “This mutation causes Gaucher’s disease, so it has clinical importance for couples who want to have children. They can request genetic screening for this specific gene mutation.”

The study involved genetic examination of 891 control patients, 436 PD patients, and 189 REM-sleep Behaviour Disorder (RBD) patients whose condition has a strong link to synucleinopathies. All PD and RBD patients were of French Canadian ancestry. The results were published in the print version of the journal Clinical Genetics on Oct. 1, 2018.

Unique brain “fingerprint” can predict drug effectiveness

In addition to The Neuro, researchers contributing to the study were from McGill University, Université Laval, Department of Pharmacology and Therapeutics (Montreal), University of Toronto, Hôpital du Sacré-Cœur de Montréal, Centre Hospitalier Universitaire Sainte-Justine (Montreal), and the Mark Freedman and Judy Jacobs Program for Gaucher Disease, Sinai Health System (Toronto).

 

This work was financially supported by the Michael J. Fox Foundation for Parkinson’s research, the Canadian Consortium on Neurodegeneration in Aging (CCNA) and the Canadian Glycomics Network (GlycoNet). This research was also undertaken thanks in part to funding from the Canada First Research Excellence Fund, awarded to McGill University for the Healthy Brains for Healthy Lives (HBHL) program. The access to part of the participants for this research has been made possible thanks to the Quebec Parkinson’s Network.

Latest articles

Canada must act quickly to turn U.S. ‘brain drain’ into Canadian ‘brain gain’: CMA

By Dr. Joss Reimer Canada must act quickly to attract the American medical and scientific...

Advancing health through innovation

On March 11, 2020, the world changed. The World Health Organization declared COVID-19 a pandemic,...

College of Physicians and Surgeons of Ontario welcomes Physician Assistants as registrants

Physician Assistants (PAs) are highly skilled professionals who provide a range of medical services...

Hospital visits for cannabis use linked to higher dementia risk, study finds

Individuals with an emergency department (ED) visit or hospitalization due to cannabis were at...

More like this

High blood pressure? Eat more bananas

New mathematical model demonstrates ratio of potassium to sodium intake key to regulating blood...

A new app can greatly improve ventriculostomy safety and accuracy

Access to potentially life-saving neurosurgical care remains very uneven worldwide, with potentially life-threatening consequences....

UHN addressing care gap in women’s heart health

Elana Trainoff didn’t think it was possible to have a heart attack at age...

Transgender and gender diverse people less likely to receive follow-up after a mental health hospitalization

Transgender and gender diverse individuals who were hospitalized for psychiatric care were less likely...

Smart radar device warns of serious heart issues

Waterloo researchers develop “super-sensitive” radar technology that can unobtrusively monitor heartbeats. Dr. George Shaker has...

Canada’s emergency departments are overwhelmed. Can patient redirection help?

Across Canada, emergency departments are facing an unprecedented surge in patient volumes, stretching resources...